HERMES BIOSCIENCES

HERMES Biosciences, Inc. engages in the development of targeted drug delivery technologies for therapeutics.

#SimilarOrganizations #People #More

HERMES BIOSCIENCES

Industry:
Biotechnology Pharmaceutical

Status:
Active


Similar Organizations

4p-therapeutics-logo

4P Therapeutics

4P Therapeutics is a private company focused on the research and development of novel drug delivery technologies and therapeutics.

Current Employees Featured

james-d-marks_image

James D. Marks
James D. Marks Founder @ Hermes Biosciences
Founder

Founder


james-d-marks_image

James D. Marks

More informations about "Hermes Biosciences"

Hermes Biosciences Company Profile 2024: Valuation, Investors ...

Hermes Biosciences General Information Description. Developer of targeted drug delivery technologies for therapeutic and other biomedical applications. The company focuses on โ€ฆSee details»

Hermes Biosciences - Crunchbase Company Profile & Funding

Organization. Hermes Biosciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Alternatives and possible competitors to Hermes โ€ฆSee details»

HERMES Biosciences - Ownership and Business Overview - Mergr

Dec 7, 2009 HERMES Biosciences was founded in 1998. Life Science M&A Summary in 2009 Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009 .See details»

Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc.

Hermes' lead candidate, MM-398, is a nanoliposomal formulation of CPT-11 that is currently in Phase 2 trials with a partner for multiple cancer indications (under the designation of PEP02). โ€ฆSee details»

Hermes Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Hermes Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 17 literature.See details»

HERMES Biosciences - Products, Competitors, Financials, โ€ฆ

About HERMES Biosciences. HERMES Biosciences specializes in the biotechnology sector with a focus on high-yield exosome isolation. The company offers a benchtop, hands-off system for โ€ฆSee details»

Merrimack Pharmaceuticals Acquires HERMES Biosciences

On December 7, 2009, Merrimack Pharmaceuticals acquired life science company HERMES Biosciences Acquisition Highlights. This is Merrimack Pharmaceuticalsโ€™ 1st transaction in the โ€ฆSee details»

Hermes Biosciences - Tech Stack, Apps, Patents & Trademarks

HERMES Biosciences, Inc. engages in the development of targeted drug delivery technologies for therapeutics.See details»

Hermes Biosciences - Drug pipelines, Patents, Clinical trials - Synapse

Explore Hermes Biosciences with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»

Hermes Biosciences - Crunchbase

HERMES Biosciences, Inc. engages in the development of targeted drug delivery technologies for therapeutics.See details»

Hermes Biosciences Inc. - BioCentury Company Profiles - BCIQ

Nov 10, 2014 Hermes Biosciences Inc. - BioCentury Company Profiles for the biopharma industrySee details»

HERMES BioSciences - Company Profile and News

Hermes Biosciences was founded in 1998. The company's line of business includes providing commercial physical and biological research and development. ...See details»

HERMES Biosciences - CB Insights

See HERMES Biosciences funding rounds, investors, investments, exits and more. Evaluate their financials based on HERMES Biosciences's post-money valuation and revenue. HERMES โ€ฆSee details»

Merrimack buys drug delivery business Hermes - outsourcing โ€ฆ

Dec 9, 2009 Hermes Biosciences has been acquired by Merrimack Pharmaceuticals in a deal which aims to combine the companiesโ€™ drug discovery and delivery platforms to develop โ€ฆSee details»

D. C. Drummond | IEEE Xplore Author Details

Affiliations: [Hermes Biosciences, South San Francisco, CA, USA]. D. C. Drummond. Affiliation. Hermes Biosciences, South San Francisco, CA, USA ... A not-for-profit organization, IEEE is โ€ฆSee details»

Merrimack ropes back international rights to cancer drug in โ€ฆ

May 9, 2011 When Merrimack Pharmaceuticals bought out Hermes Biosciences near the end of 2009, it touted the prospects for the UCSF spinout's lead drug, MM-398, then in mid-stage โ€ฆSee details»

Hermes Biosciences - Contacts, Employees, Board Members

Organization. Hermes Biosciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Hermes โ€ฆSee details»

Hermes Bioscience - PitchBook

Hermes Bioscienceโ€™s primary industry is Other Healthcare Technology Systems. Is Hermes Bioscience a private or public company? Hermes Bioscience is a Private company. What is โ€ฆSee details»

Landing Page | Hermes Life Sciences

Hermes Life Sciences is now LoBio! bottom of page. top of page. Technology. COVID-19. Team. Contact. Hermes Life Sciences is now LoBio! bottom of page ...See details»

Hermes Life Sciences - Funding, Financials, Valuation & Investors

Hermes Life Sciences develops solutions to improve the accuracy and accessibility of blood testing at the point-of-care. Search Crunchbase. Start Free Trial . ... How much funding has โ€ฆSee details»

linkstock.net © 2022. All rights reserved